Page last updated: 2024-11-07

carbachol and Neoplasms, Nervous System

carbachol has been researched along with Neoplasms, Nervous System in 4 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Research Excerpts

ExcerptRelevanceReference
" The effect of mastoparan, a wasp venom toxin, on intracellular free Ca2+ concentration ([Ca2+]i) was examined in human astrocytoma cells."7.69Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells. ( Ishimoto, H; Mizuno, K; Nakahata, N; Nakanishi, H; Ohizumi, Y, 1994)
" The effect of mastoparan, a wasp venom toxin, on intracellular free Ca2+ concentration ([Ca2+]i) was examined in human astrocytoma cells."3.69Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells. ( Ishimoto, H; Mizuno, K; Nakahata, N; Nakanishi, H; Ohizumi, Y, 1994)
" In a well-characterized human oligodendroglioma (HOG) cell line, PL-C (measured by release of [3H]inositol phosphates) and PL-D (formation of [3H]myristoylated or palmitoylated phosphatidylethanol) were activated by both carbachol (blocked by pirenzepine, suggesting an M1 receptor) and histamine (H1 receptor) but not glutamate, bradykinin, or phenylephrine."3.68Regulation of phospholipase D activity in a human oligodendroglioma cell line (HOG). ( Dawson, G; Dawson, SA; Post, GR, 1993)
"The addition of bradykinin to populations of fura-2 loaded N1E-115 neuroblastoma cells produced an increase in intracellular calcium which rapidly reached a peak and returned to baseline within 60 s."3.68Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol. ( Hill, SJ; Iredale, PA; Kendall, DA; Martin, KF, 1992)
"The effect of calcium channel antagonists on depolarization and carbachol evoked release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y, was investigated."3.68The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y. ( Ball, SG; Murphy, NP; Vaughan, PF, 1991)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakahata, N1
Ishimoto, H1
Mizuno, K1
Ohizumi, Y1
Nakanishi, H1
Dawson, G1
Dawson, SA1
Post, GR1
Iredale, PA1
Martin, KF1
Hill, SJ1
Kendall, DA1
Murphy, NP1
Ball, SG1
Vaughan, PF1

Other Studies

4 other studies available for carbachol and Neoplasms, Nervous System

ArticleYear
Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells.
    British journal of pharmacology, 1994, Volume: 112, Issue:1

    Topics: Astrocytoma; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Fura-2; GTP-Bin

1994
Regulation of phospholipase D activity in a human oligodendroglioma cell line (HOG).
    Journal of neuroscience research, 1993, Feb-15, Volume: 34, Issue:3

    Topics: Alkaloids; Carbachol; Chromatography, Thin Layer; Down-Regulation; Enzyme Activation; Histamine; Hum

1993
Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol.
    European journal of pharmacology, 1992, Jun-05, Volume: 226, Issue:2

    Topics: Bradykinin; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Fura-2; Humans;

1992
The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
    Neuroscience letters, 1991, Aug-19, Volume: 129, Issue:2

    Topics: Calcium Channel Blockers; Carbachol; Cations, Divalent; Cell Line; Humans; Nervous System Neoplasms;

1991